Hunan Warrant Pharmaceutical Co., Ltd. Class ASSE: 688799

"Hunan Warrant Pharmaceutical Co., Ltd."Indicative Announcement on Change in Equity Interests of the Controlling Shareholder and Its Person Acting in Concert Reaching 1% Threshold

Sep 18, 2026 · Issued by Hunan Warrant Pharmaceutical Co., Ltd. Class A via Shanghai Stock Exchange

Filed with SSE · Sep 18, 2026

Indicative Announcement on Change in Equity Interests of the Controlling Shareholder and Its Person Acting in Concert Reaching 1% Threshold

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment

6ix hasn’t read this filing yet.

Company analysis

Earlier from Hunan Warrant Pharmaceutical Co., Ltd. Class A

"Hunan Warrant Pharmaceutical Co., Ltd."Announcement on Participating in the 2026 Semi-annual Collective Performance Briefing for the STAR Market Innovative Drug IndustrySep 9
"Hunan Warrant Pharmaceutical Co., Ltd."Announcement on Voluntary Disclosure of the Subsidiary's Obtaining of the Approval Notice for Its API Marketing ApplicationSep 3
"Hunan Warrant Pharmaceutical Co., Ltd."Announcement on Voluntary Disclosure of Obtaining Drug Registration CertificateSep 1
"Hunan Warrant Pharmaceutical Co., Ltd."Indicative Announcement on Shareholding Reduction Plan of Controlling Shareholder and Proposed Change of Shareholding Form by the Controlling Shareholder's PartnerAug 26

All Hunan Warrant Pharmaceutical Co., Ltd. Class A news releases